fashion -WSS

fashion

author：leisure time 2025-10-01 15:30:30 - browse：2

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： European officials brace for rough respiratory virus season

hotspot

entertainment

WSS

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

The Karikó problem: Lessons for funding basic research

The United States is paying nearly triple for new Covid vaccines

Poor hospice wound care hurts patients and families

David Sabatini, ex

Why medical students are struggling with mental health

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

After affirmative action ruling, medical educators look to 'holistic review'

Lawsuit highlights wrinkle for disputes over surprise medical bills

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

United colonoscopy coverage change 'may cost lives,' doctors say

Gain of function research would be limited under House proposal

The high cost of giving birth even with insurance

With Roe v Wade overturned, abortion providers work to adapt

Moonlake's readout produced a cash windfall. Risks remain

Anthos stroke drug appears safer than common blood thinner

entertainment

In key trial, Verve's treatment lowers cholesterol levels in patients

Congress extends some pandemic preparedness programs

What we owe ALS patients — and why one company fell short

The stability of $0 premiums in Medicare Advantage

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Stop Congress from blocking public access to science

knowledge

hotspot

entertainment

Wikipedia